Stock C4XD C4X DISCOVERY HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials C4X Discovery Holdings plc

Equities

C4XD

GB00BQQ2RV18

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:46:00 2024-04-25 am EDT 		5-day change 1st Jan Change
12 GBX +27.32% Intraday chart for C4X Discovery Holdings plc +45.90% +33.33%
Apr. 25 Norcros sells Johnson Tiles UK; Trifast trading well AN
Apr. 25 C4X Discovery Set for Friday Delisting from London Bourse's AIM MT

Valuation

Fiscal Period: July 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 26.87 20.05 71.41 61.43 50.93 30.27 - -
Enterprise Value (EV) 1 24.49 14.4 54.31 56.36 46.71 8.037 14.51 19.5
P/E ratio - - - - -4.57 x 1.74 x -4.29 x -5.58 x
Yield - - - - - - - -
Capitalization / Revenue - - 12.7 x 22.8 x 29.8 x 1 x 5.1 x 3.73 x
EV / Revenue - - 9.63 x 20.9 x 27.3 x 0.27 x 2.45 x 2.4 x
EV / EBITDA -1.82 x -1.53 x -9.41 x -5.37 x -3.57 x 0.55 x -1.47 x -2.4 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 57,793 108,366 226,713 229,232 252,120 252,227 - -
Reference price 2 0.4650 0.1850 0.3150 0.2680 0.2020 0.1200 0.1200 0.1200
Announcement Date 1/7/20 12/10/20 12/13/21 12/15/22 12/14/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - 5.642 2.699 1.71 30.23 5.93 8.11
EBITDA 1 -13.45 -9.383 -5.772 -10.49 -13.08 14.65 -9.88 -8.12
EBIT 1 -13.64 -9.566 -5.893 -10.52 -13.41 14.6 -9.9 -8.2
Operating Margin - - -104.45% -389.85% -784.44% 48.3% -166.95% -101.11%
Earnings before Tax (EBT) 1 - - - - -13.42 15.2 -9.1 -7.6
Net income 1 - - - - -11.11 17.5 -6.9 -5.4
Net margin - - - - -649.77% 57.89% -116.36% -66.58%
EPS 2 - - - - -0.0442 0.0690 -0.0280 -0.0215
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 1/7/20 12/10/20 12/13/21 12/15/22 12/14/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: July 2020 S1 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales 1 - - 5.64 0.066 2.633 1.676 0.034
EBITDA 1 -4.797 -4.436 -1.35 -5.515 -4.976 -5.163 -8.056
EBIT 1 -4.889 -4.521 - -5.53 -4.992 -5.178 -8.236
Operating Margin - - - -8,378.79% -189.59% -308.95% -24,223.53%
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/29/20 4/29/21 12/13/21 4/28/22 12/15/22 4/26/23 12/14/23
1GBP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: July 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 2.38 5.65 17.1 5.08 4.22 22.2 15.8 10.8
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share 2 -0.2200 0.1800 -0.0100 -0.0500 -0.0200 0.0700 -0.0300 -0.0200
Capex 1 0.05 - 0.02 0.04 0.02 0.1 0.1 0.1
Capex / Sales - - 0.35% 1.37% 1.05% 0.33% 1.69% 1.23%
Announcement Date 1/7/20 12/10/20 12/13/21 12/15/22 12/14/23 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for C4X Discovery Holdings plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.12 GBP
Average target price
0.48 GBP
Spread / Average Target
+300.00%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
C4X DISCOVERY HOLDINGS PLC Stock C4X Discovery Holdings plc
+33.33% 37.7M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. C4XD Stock
  4. Financials C4X Discovery Holdings plc